LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Drillich, Ann"
  2. AU="Bennett, Hamilton"
  3. AU="Al Kaabi, Hoor"
  4. AU="Hecht, Harvey S"
  5. AU="Minsky, Bruce D"
  6. AU="Manzano, Joanna-Grace M"
  7. AU="Acín-Pérez, Rebeca"
  8. AU="Kamakura, Tsukasa"
  9. AU="Lee, Theodore K"
  10. AU="So, Marvin"

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel ; Online: Refugee experiences of general practice in countries of resettlement: a literature review.

    Cheng, I-Hao / Drillich, Ann / Schattner, Peter

    The British journal of general practice : the journal of the Royal College of General Practitioners

    2015  Band 65, Heft 632, Seite(n) e171–6

    Abstract: Background: Refugees and asylum seekers often struggle to use general practice services in resettlement countries.: Aim: To describe and analyse the literature on the experiences of refugees and asylum seekers using general practice services in ... ...

    Abstract Background: Refugees and asylum seekers often struggle to use general practice services in resettlement countries.
    Aim: To describe and analyse the literature on the experiences of refugees and asylum seekers using general practice services in countries of resettlement.
    Design and setting: Literature review using systematic search and narrative data extraction and synthesis methodologies. International, peer-reviewed literature published in English language between 1990 and 2013.
    Method: Embase, Ovid MEDLINE, PsycINFO, CSA Sociological Abstracts, and CINAHL databases were searched using the terms: refugee, asylum seeker, experience, perception, doctor, physician, and general practitioner. Titles, abstracts and full texts were reviewed and were critically appraised. Narrative themes describing the refugee or asylum seeker's personal experiences of general practice services were identified, coded, and analysed.
    Results: From 8722 papers, 85 were fully reviewed and 23 included. These represented the experiences of approximately 864 individuals using general practice services across 11 countries. Common narrative themes that emerged were: difficulties accessing general practice services, language barriers, poor doctor-patient relationships, and problems with the cultural acceptability of medical care.
    Conclusion: The difficulties refugees and asylum seekers experience accessing and using general practice services could be addressed by providing practical support for patients to register, make appointments, and attend services, and through using interpreters. Clinicians should look beyond refugee stereotypes to focus on the needs and expectations of the individual. They should provide clear explanations about unfamiliar clinical processes and treatments while offering timely management.
    Mesh-Begriff(e) Communication Barriers ; Cultural Competency ; General Practice/organization & administration ; Health Knowledge, Attitudes, Practice ; Health Services Accessibility/organization & administration ; Humans ; Patient Acceptance of Health Care/ethnology ; Patient Acceptance of Health Care/psychology ; Physician-Patient Relations ; Referral and Consultation/organization & administration ; Refugees/psychology ; Refugees/statistics & numerical data ; Social Support ; Socioeconomic Factors ; United Nations
    Sprache Englisch
    Erscheinungsdatum 2015-03
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1043148-2
    ISSN 1478-5242 ; 0035-8797 ; 0960-1643
    ISSN (online) 1478-5242
    ISSN 0035-8797 ; 0960-1643
    DOI 10.3399/bjgp15X683977
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel: Androgen therapy in women: what we think we know.

    Drillich, Ann / Davis, Susan R

    Experimental gerontology

    2007  Band 42, Heft 6, Seite(n) 457–462

    Abstract: To date there is no clinical indication for the use of testosterone in women and long-term safety data is lacking. This minireview examines androgen therapy in women. Issues relating to research into sexual function and androgens in women are discussed. ... ...

    Abstract To date there is no clinical indication for the use of testosterone in women and long-term safety data is lacking. This minireview examines androgen therapy in women. Issues relating to research into sexual function and androgens in women are discussed. Androgen physiology is described and studies examining endogenous androgens in women cited. A Cochrane review found that adding testosterone to a hormone therapy regimen has beneficial effects on sexual function in postmenopausal women and subsequent studies have supported the role of testosterone in sexual function and well-being. However studies on safety and efficacy of testosterone beyond 24 weeks are lacking.
    Mesh-Begriff(e) Aged ; Androgens/adverse effects ; Androgens/physiology ; Androgens/therapeutic use ; Female ; Humans ; Menopause/drug effects ; Menopause/physiology ; Middle Aged ; Sexual Behavior/drug effects ; Sexual Behavior/physiology ; Testosterone/adverse effects ; Testosterone Congeners/adverse effects ; Testosterone Congeners/therapeutic use
    Chemische Substanzen Androgens ; Testosterone Congeners ; Testosterone (3XMK78S47O)
    Sprache Englisch
    Erscheinungsdatum 2007-06
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 390992-x
    ISSN 0531-5565
    ISSN 0531-5565
    DOI 10.1016/j.exger.2007.02.005
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.

    Davis, Susan R / Stuckey, Bronwyn G A / Norman, Robert J / Papalia, Mary-Anne / Drillich, Ann / Bell, Robin J

    Menopause (New York, N.Y.)

    2008  Band 15, Heft 6, Seite(n) 1065–1069

    Abstract: Objective: Oral estrogen therapy suppresses insulin like growth factor I (IGF-I) levels, whereas conventional dose transdermal estradiol (E2) does not. However, it has been proposed that if sufficiently high serum E2 levels are achieved, nonoral E2 will ...

    Abstract Objective: Oral estrogen therapy suppresses insulin like growth factor I (IGF-I) levels, whereas conventional dose transdermal estradiol (E2) does not. However, it has been proposed that if sufficiently high serum E2 levels are achieved, nonoral E2 will also suppress serum IGF-I. The aim of the study was to investigate the effects of intranasal E2 with norethisterone (E2/NET) versus oral E2/NET acetate on IGF-I, IGF binding protein 3, and insulin resistance in postmenopausal women.
    Design: This was a randomized, multicenter, double-blind, double-dummy trial. Postmenopausal women were randomized to receive either daily intranasal E2/NET (175 microg/275 microg) as a spray and a placebo tablet (n = 41) or oral E2/NET acetate (1 mg/0.5 mg) plus placebo intranasal spray (n = 41) for 1 year. Fasting plasma concentrations of IGF-I, IGF binding protein 3, glucose and insulin, glucose and insulin at 120 minutes post-glucose challenge, and the homeostasis model assessment for insulin resistance were assessed at baseline and after 52 weeks of treatment.
    Results: The two groups were well matched for all clinical and biochemical parameters at baseline. There were no significant between-group differences for fasting and 120-minute glucose, insulin, homeostasis model assessment for insulin resistance, and IGF binding protein 3. The mean IGF-I level at week 52 was significantly lower for women treated with oral versus intranasal therapy (116 +/- 21 [SD] versus 134 +/- 33 [SD], P = 0.005) and the mean difference in change over 52 weeks in IGF-I was significantly different between groups (-19, 95% CI:-37 to -1, P = 0.04).
    Conclusions: In healthy postmenopausal women, intranasal E2 at a dose that results in serum levels that exceed the proposed threshold for growth hormone and IGF-I effects, does not alter IGF-I levels. This suggests that the effect of exogenous estrogen on IGF-I is a function of the method of administration rather than being dose related.
    Mesh-Begriff(e) Administration, Intranasal ; Administration, Oral ; Cardiovascular Diseases ; Dose-Response Relationship, Drug ; Estradiol/administration & dosage ; Estradiol/adverse effects ; Estrogen Replacement Therapy/adverse effects ; Female ; Glucose Tolerance Test ; Humans ; Insulin Resistance ; Insulin-Like Growth Factor Binding Protein 3/drug effects ; Insulin-Like Growth Factor I/drug effects ; Middle Aged ; Norethindrone/administration & dosage ; Norethindrone/adverse effects ; Postmenopause/drug effects
    Chemische Substanzen Insulin-Like Growth Factor Binding Protein 3 ; Estradiol (4TI98Z838E) ; Insulin-Like Growth Factor I (67763-96-6) ; Norethindrone (T18F433X4S)
    Sprache Englisch
    Erscheinungsdatum 2008-11
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Multicenter Study ; Randomized Controlled Trial
    ZDB-ID 1205262-0
    ISSN 1530-0374 ; 1072-3714
    ISSN (online) 1530-0374
    ISSN 1072-3714
    DOI 10.1097/gme.0b013e318174f16e
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang